Evidence map›Paper›PMID 33766561›Full record

ArticleThe Journal of biological chemistry

DDX3X coordinates host defense against influenza virus by activating the NLRP3 inflammasome and type I interferon response.

Sannula Kesavardhana, Parimal Samir, Min Zheng, R K Subbarao Malireddi, Rajendra Karki, Bhesh Raj Sharma, David E Place, Benoit Briard, Peter Vogel, Thirumala-Devi Kanneganti

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. RNA helicase DDX3X promotes NK cell survival by supporting MCL1 expression.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sannula KesavardhanaDepartment of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Parimal SamirDepartment of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Min ZhengDepartment of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
R K Subbarao MalireddiDepartment of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Rajendra KarkiDepartment of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Bhesh Raj SharmaDepartment of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
David E PlaceDepartment of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Benoit BriardDepartment of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Peter VogelAnimal Resources Center and the Veterinary Pathology Core, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Thirumala-Devi KannegantiDepartment of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Electronic address: Thirumala-Devi.Kanneganti@StJude.org.
St. Jude Children's Research Hospital · US

Funding

Innate immune sensors, inflammasomes, and inflammasome-mediated processes in cancerR35CA253095 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Thirumala-Devi Kanneganti · 2020 to 2026
$7.0M
Role of NLR Inflammasomes in Autoinflammatory Diseases and Host DefenseR01AR056296 · NIAMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KANNEGANTI, THIRUMALA-DEVI · 2008 to 2022
$5.9M
The Non-Inflammasome NLRs in Immunity and Host defenseR01AI124346 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Thirumala-Devi Kanneganti · 2016 to 2026
$5.8M
Inflammatory Caspases in Innate Immunity and InflammationR37AI101935 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Thirumala-Devi Kanneganti · 2017 to 2026
$4.9M
Inflammatory Caspases in Innate Immunity and InflammationR01AI101935 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KANNEGANTI, THIRUMALA-DEVI · 2012 to 2016
$2.2M
NCI NIH HHS R35 CA253095NIAID NIH HHS R01 AI101935NIAID NIH HHS R01 AI124346NIAID NIH HHS R37 AI101935NIAMS NIH HHS R01 AR056296
6 · The paper itself

Abstract

Viruses and hosts have coevolved for millions of years, leading to the development of complex host-pathogen interactions. Influenza A virus (IAV) causes severe pulmonary pathology and is a recurrent threat to human health. Innate immune sensing of IAV triggers a complex chain of host responses. IAV has adapted to evade host defense mechanisms, and the host has coevolved to counteract these evasion strategies. However, the molecular mechanisms governing the balance between host defense and viral immune evasion is poorly understood. Here, we show that the host protein DEAD-box helicase 3 X-linked (DDX3X) is critical to orchestrate a multifaceted antiviral innate response during IAV infection, coordinating the activation of the nucleotide-binding oligomerization domain-like receptor with a pyrin domain 3 (NLRP3) inflammasome, assembly of stress granules, and type I interferon (IFN) responses. DDX3X activated the NLRP3 inflammasome in response to WT IAV, which carries the immune evasive nonstructural protein 1 (NS1). However, in the absence of NS1, DDX3X promoted the formation of stress granules that facilitated efficient activation of type I IFN signaling. Moreover, induction of DDX3X-containing stress granules by external stimuli after IAV infection led to increased type I IFN signaling, suggesting that NS1 actively inhibits stress granule-mediated host responses and DDX3X-mediated NLRP3 activation counteracts this action. Furthermore, the loss of DDX3X expression in myeloid cells caused severe pulmonary pathogenesis and morbidity in IAV-infected mice. Together, our findings show that DDX3X orchestrates alternate modes of innate host defense which are critical to fight against NS1-mediated immune evasion strategies during IAV infection.

Indexed as

Immunity, InnateAnimalsDEAD-box RNA HelicasesInflammasomesInfluenza A virusInterferon Type IMiceNLR Family, Pyrin Domain-Containing 3 ProteinDdx3x protein, mouseDEAD-box RNA HelicasesInflammasomesInterferon Type INLR Family, Pyrin Domain-Containing 3 ProteinDDX3Xhost defenseimmune evasioninflammasomeinfluenza A virusinnate immunityNLRP3NS1stress granuletype I IFN

Identifiers

PMID33766561
PMCPMC8081917
OpenAlexW3136303338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.